Table 1.
Baseline demographics of the study participants
| Total | Genotype |
P value | |||
|---|---|---|---|---|---|
| TT | CT | CC | |||
| SUGAR-MGH, n | 608 | 55 | 242 | 311 | |
| Male sex, n (%) | 25 (45.6) | 125 (51.7) | 142 (45.7) | 0.347 | |
| Age (years) | 48.7 ± 16 | 50 ± 16 | 50 ± 16 | 47 ± 16.3 | 0.111 |
| BMI (kg/m2) | 30.6 ± 7 | 29.6 ± 7 | 30.4 ± 6 | 30.9 ± 7 | 0.339 |
| Fasting glucose (mg/dL) | 93.2 ± 14 | 98.3 ± 20 | 93 ± 13 | 92 ± 12 | 0.012 |
| Fasting insulin (mU/L) | 7.2 ± 8 | 7.6 ± 6 | 7.2 ± 6 | 7.5 ± 6 | 0.867 |
| C-peptide (pmol/L) | 810 ± 391 | 820 ± 368 | 830 ± 390 | 793 ± 396 | 0.559 |
| Lifestyle-controlled T2D, n (%) | 15 (2.5) | 5 (9.1) | 6 (2.5) | 4 (1.3) | 0.003 |
Data are mean ± SD unless otherwise noted. T2D, type 2 diabetes.